CD20 role in pathophysiology of Hodgkin's disease
Rev. Assoc. Med. Bras. (1992); 63 (9), 2017
Summary Hodgkin's lymphoma (HL) is a tumor comprising non-malignant and malignant B-cells. Classical HL expresses CD15+ and CD30+ antigens, and 20 to 40% of patients are CD20+. This antigen is a ligand free protein present in B lymphocyte cells and its function is not well known. Some studies suggest tha...